  Heart failure is a leading cause of mortality in the Western world. The mouse
is a widely used model for a number of diseases, induced by genetic
modification or surgical intervention. When performing experiments in mice, in
vivo magnetic resonance imaging (MRI) can be used to evaluate heart anatomy and
function at multiple levels. Volumetric measurements of ventricle size at each
phase of the heart cycle (obtained with cine MRI) can be used as a sensitive
measure for heart failure. Cine MRI is applied here to genetic models of heart
disease, including stress tests with pharmacological manipulation. As the long
duration of the acquisition for functional assessment is a critical limitation,
a new method to make cine MRI twelve times faster is presented and validated,
maintaining standard accuracy. The method utilises a combination of compressed
sensing and parallel imaging with a radial acquisition of k-space. Eddy-current
induced artifacts, present when acquiring radially, are corrected
retrospectively with a novel scheme. Tissue viability can be measured with late
gadolinium enhancement (LGE) imaging, where a contrast agent is utilised. After
injection, the agent rapidly washes out of healthy tissue, though has a slower
kinetic in infarcted regions. A novel method to perform LGE efficiently is
presented and validated against histology. This method is applied to the
evaluation of a new treatment for infarction. Finally, a novel method to
perform a multi-modal assessment of the mouse heart within a single exam is
presented. The method includes cine and LGE MRI as well as a measure of
mechanical strain in the myocardium with displacement encoding with stimulated
echoes (DENSE) MRI and assessment of cellular metabolism with positron emission
tomography (PET). This method is demonstrated in the evaluation of a new
protective agent for infarction.
